In a disturbing development for the American healthcare system, the federal government has effectively halted most of the Agency for Healthcare Research and Quality’s (AHRQ) activities, closing the spigot on funding that has historically saved thousands of lives and billions of dollars.

According to a comprehensive investigation published in early August 2026, the small Department of Health and Human Services (HHS) agency has halted at least 104 grants, many of which were explicitly aimed at improving patient safety and medical practice. Despite Congress appropriating $345 million for AHRQ for the current fiscal year, the agency has spent less than $15 million on grants and has not issued a new one in over a year.

A Sharp Decline in Agency Capacity

The volte-face in funding comes alongside a massive reduction in workforce. Approximately 75% of AHRQ staffers have been fired or have resigned since the current administration took office, according to HHS data. Critics argue that gutting an agency with a noncontroversial focus on patient safety is profoundly shortsighted.

"When you think about everything Americans hate about our healthcare system — that it costs too much, that you can’t get in to see a physician, that the treatment isn’t right — all that is what AHRQ studies," noted Aaron Carroll, chief executive of AcademyHealth, a prominent health services research group.

The Ripple Effect on Medical Innovation

Researchers who received termination notices expressed bewilderment, as much of their canceled work directly aligned with the agency’s stated priorities. For over two decades, AHRQ-funded research has been paramount in curbing hospital infections, structuring medical information technology, and introducing patient-centered care into the health system.

An analysis by the agency previously estimated that practices introduced because of AHRQ-funded studies prevented approximately 20,500 deaths and saved $7.7 billion in healthcare costs between 2014 and 2017 alone. Now, with grant managers fired and funding frozen, scientists are left scrambling to salvage multi-year projects aimed at reducing medical errors and improving care in rural communities.

Legal Challenges and Future Uncertainty

The situation has sparked scrutiny and legal action. The Society for General Internal Medicine recently filed a lawsuit arguing that the failure to use most of AHRQ’s congressionally appropriated budget is illegal under a 1974 law intended to protect Congress’ power of the purse.

As the healthcare policy landscape continues to shift, the dismantling of this critical research infrastructure raises profound questions about the nation’s long-term commitment to evidence-based medicine. Without robust federal support for health services research, experts warn that the foundational pillars of patient safety and quality improvement risk disintegration.